Wednesday 6 November 2024
Home
 
»
Tag
 
»
Ocrelizumab

Roche suspends RA treatment after deaths

Swiss drugmaker Roche Holding AG  and America's Biogen Idec are suspending rheumatoid arthritis and lupus treatment Ocrelizumab after it caused deaths, marking the latest setback for Roche's pipeline. A safety monitoring board said it

More…
 1 2 3 4 5 >  Last ›

calendarCalendar of Events

Tools

exchangeExchange Rates
exchangeWeather Forecast
exchangeBBC World Service

Ads

Sectors |

Information |

About Us |